Januvia Sales Data

Rank 14 Current sales rank, all
U.S. Pharmaceuticals.

Last updated: February 2014 (updated quarterly).
The following data shows Januvia U.S. retail sales in Q4 2013 compared to previous quarters.

Date Range Sales Rank Sales ($000) Units (000)
Q4 2013 14 (1) 3.63% -2.78%
Q3 2013 15 (1) -2.33% -6.26%
Q2 2013 14 -1.23% 0.04%
Q1 2013 14 (1) 6.40% 0.38%
Q4 2012 15 1.18% 1.89%
Q3 2012 15 (4) 7.50% 1.17%
Q2 2012 19 (3) 3.81% 3.19%
Q1 2012 22 (1) 7.89% 4.41%
Q4 2011 23 (1) 4.87% 4.35%
Q3 2011 24 1.19% 0.79%
Q2 2011 24 (3) 8.81% 3.89%
Q1 2011 27

* Units refer to the number of packages sold.

Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.

Related News

DateArticle
September 22, 2011Popular Diabetes Drugs May Raise Pancreatic Cancer Risk, Study Suggests
June 13, 2011FDA Approves Redesigned Labels for Some Merck Drugs
June 9, 2008New Data Released at Major Diabetes Meeting on Initial Combination Therapy with Januvia (sitagliptin), Merck's Diabetes Medicine, and Metformin through Two Years of Treatment
Hide
(web2)